These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16698271)

  • 21. Map kinase phosphatases (MKP's) are early responsive genes during induction of cerulein hyperstimulation pancreatitis.
    Höfken T; Keller N; Fleischer F; Göke B; Wagner AC
    Biochem Biophys Res Commun; 2000 Sep; 276(2):680-5. PubMed ID: 11027531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
    Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY; Liu Y; Wu GS
    Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors.
    Arnold DM; Foster C; Huryn DM; Lazo JS; Johnston PA; Wipf P
    Chem Biol Drug Des; 2007 Jan; 69(1):23-30. PubMed ID: 17313454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): structure-based design of MKP-1 inhibitors and upregulators.
    Doddareddy MR; Rawling T; Ammit AJ
    Curr Med Chem; 2012; 19(2):163-73. PubMed ID: 22320295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
    Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
    J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
    Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
    EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
    Kar S; Wang M; Yao W; Michejda CJ; Carr BI
    Mol Cancer Ther; 2006 Jun; 5(6):1511-9. PubMed ID: 16818510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
    Todd JL; Rigas JD; Rafty LA; Denu JM
    Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cAMP-induced arylalkylamine N-acetyltransferase, Period1, and MKP-1 gene expression by mitogen-activated protein kinases in the rat pineal gland.
    Chansard M; Iwahana E; Liang J; Fukuhara C
    Brain Res Mol Brain Res; 2005 Oct; 139(2):333-40. PubMed ID: 16024134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1.
    Kassel O; Sancono A; Krätzschmar J; Kreft B; Stassen M; Cato AC
    EMBO J; 2001 Dec; 20(24):7108-16. PubMed ID: 11742987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
    Kim KR; Kwon JL; Kim JS; No Z; Kim HR; Cheon HG
    Eur J Pharmacol; 2005 Dec; 528(1-3):37-42. PubMed ID: 16324698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
    Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
    Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
    Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
    Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1676-81. PubMed ID: 15242861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway.
    Todd JL; Tanner KG; Denu JM
    J Biol Chem; 1999 May; 274(19):13271-80. PubMed ID: 10224087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular effects of small molecule PTP1B inhibitors on insulin signaling.
    Xie L; Lee SY; Andersen JN; Waters S; Shen K; Guo XL; Moller NP; Olefsky JM; Lawrence DS; Zhang ZY
    Biochemistry; 2003 Nov; 42(44):12792-804. PubMed ID: 14596593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.